Pediatrix Medical Group/$MD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Pediatrix Medical Group

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

Ticker

$MD

Primary listing

NYSE

Industry

Health Care Providers & Services

Employees

4,120

ISIN

US58502B1061

MD Metrics

BasicAdvanced
$1.1B
-
-$0.99
1.27
-

What the Analysts think about MD

Analyst ratings (Buy, Hold, Sell) for Pediatrix Medical Group stock.

Bulls say / Bears say

Pediatrix Medical Group's strategic exit from non-core office-based practices is projected to enhance annual Adjusted EBITDA by approximately $30 million, indicating a focused approach to core hospital-based services. (businesswire.com)
The company's stock has surged 80.9% over the past six months, significantly outperforming the industry average, suggesting strong investor confidence and potential for continued growth. (nasdaq.com)
Analysts have set a consensus 12-month price target of $18.36 for Pediatrix Medical Group, representing a potential upside of over 30% from the current share price, reflecting positive market sentiment. (simplywall.st)
Pediatrix Medical Group reported a net loss of $124 million in Q4 2023, raising concerns about its profitability and financial stability. (finance.yahoo.com)
The company's return on capital employed has remained flat over the past five years, despite a 62% reduction in capital employed, indicating potential inefficiencies and challenges in generating returns. (finance.yahoo.com)
Analysts have been regularly downgrading their EPS expectations for Pediatrix Medical Group over the past 12 months, suggesting a bearish outlook on the company's future earnings potential. (marketscreener.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.

MD Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

MD Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MD

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs